Federal contractor profile

THERALYTIX LLC

UEI Q2P9NPCFSDC7CAGE 95TY3Company website ↗

Active

Small Business

Overview

Legal name: THERALYTIX LLC
Registered location: RENO, NV, USA
Website: Company website ↗
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Latest award activity: May 21, 2026

Read company summary

THERALYTIX LLC is associated with UEI Q2P9NPCFSDC7 and CAGE 95TY3 in public federal records. AcornBids currently links 1 prime award totaling $1.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists RENO, NV, USA.

At a glance

Lifetime prime obligations$1.2M

Prime awards1

Awards with future end dates1

Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: THERALYTIX LLC
UEI: Q2P9NPCFSDC7
CAGE: 95TY3
Registered address: 3825 SNIPE DR, RENO, NV, 89508, USA
Registration status: Active
Primary NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
SAM activation: Apr 16, 2026
Initial registration: Jul 29, 2021
Entity start: May 1, 2019
SAM updated: Apr 16, 2026
Registration expires: Apr 14, 2027
Fiscal year end: Dec 31
Place of incorporation: NV, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
FA864925P0323CLEARANCE OF PATHOGENS CAUSING DIARRHEA, DYSENTERY AND URINARY TRACT INFECTIONS	Department of Defense	$1.2M	Jul 24, 2025	Apr 26, 2027

Explore, filter and export all awards →Subcontracts Grants & subgrants

Upcoming positioning windows

Modeled recompete windows are estimates, not announced solicitations or guarantees.

CLEARANCE OF PATHOGENS CAUSING DIARRHEA, DYSENTERY AND URINARY TRACT INFECTIONS

Department of Defense$1.2M obligationsEnds Apr 26, 202750% recompete estimate

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Apr 16, 2026
Source loaded	Sep 26, 2026
Initial registration	Jul 29, 2021
Entity start	May 1, 2019

Registration classifications: Small Business. These are separate from the reported certificates above.

Industry	Reported size status
541714 — Research and Development in Biotechnology (except Nanobiotechnology)	Not reported

Contact	Role	Published contact methods	Evidence	Source date
CHRISTOPHER SMITH	Government business	Contact method not published	SAM registration	Not available
CHRISTOPHER SMITH	Alternate government business	Contact method not published	SAM registration	Not available
CHRISTOPHER SMITH	Electronic business	Contact method not published	SAM registration	Not available
CHRISTOPHER SMITH	Alternate electronic business	Contact method not published	SAM registration	Not available

Registered industries

541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registered products and services

AJ12 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source